GZL-23520-29543 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-03-10
Registered in v-safe
2021-03-10
Dose 1 — Pfizer-BioNTech
2021-03-10
Health check-in — day 0, dose 1
Feeling: Fair · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness

Adult check-in
2021-03-11
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Site: Pain · Fatigue or tiredness

Adult check-in
2021-03-12
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Site: Pain · None

Adult check-in
2021-03-13
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-03-16
Health check-in — days 1–6 daily, dose 1
Feeling: Fair · Fatigue or tiredness, Nausea, Abdominal pain

Adult check-in
2021-03-17
Health check-in — day 7, dose 1
Feeling: Fair · Headache, Joint pains, Fatigue or tiredness

Adult check-in
2021-03-24
Survey response — day 14, dose 1
MedDRA: Headache, Pain, Vision blurred — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

Free text: Body aches, blurred vision, headache

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-03-24
Report sent to call center — day 14, dose 1
Get care from a doctor or other healthcare professional

1 call case(s)
2021-03-31
Dose 2 — Pfizer-BioNTech
2021-03-31
Survey response — day 0, dose 2
MedDRA: Dizziness — Feeling: Fair · Site: Pain · Fever · Chills, Joint pains, Muscle or body aches, Fatigue or tiredness

Free text: Dizziness

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-03
Survey response — days 1–6 daily, dose 2
MedDRA: Dizziness, Vision blurred — Feeling: Poor · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to do your normal daily activities

Free text: Dizziness and blurred vision

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-04
Survey response — days 1–6 daily, dose 2
MedDRA: Dizziness, Vision blurred — Feeling: Fair · Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activities

Free text: Dizziness and blurred vision

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-05
Survey response — days 1–6 daily, dose 2
MedDRA: Dizziness — Feeling: Fair · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness

Free text: Dizziness

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-06
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness

Adult check-in
2021-04-14
Health check-in — day 14, dose 2
Feeling: Good

Adult check-in
2021-04-21
Health check-in — day 21, dose 2
Feeling: Fair

Adult check-in
2021-04-28
Health check-in — day 28, dose 2
Feeling: Fair

Adult check-in
2021-09-30
Survey response — 6 months, dose 2
MedDRA: Menstrual disorder — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

Free text: Worsening mensural cycles

MedDRA releases: 2024-11 · check-in free text available
2021-09-30
Report sent to call center — 6 months, dose 2
Get care from a doctor or other healthcare professional

Outpatient clinic or urgent care clinic visit · 1 call case(s)
2021-10-01
Call 1 — Left Voicemail
2022-04-02
Survey response — 12 months, dose 2
MedDRA: Abortion spontaneous — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit

Free text: 2 miscarriages

MedDRA releases: 2024-11 · check-in free text available
2022-04-02
Report sent to call center — 12 months, dose 2
Get care from a doctor or other healthcare professional

Telehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
2022-04-04
Call 1 — Left Voicemail

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-03-10	Pfizer-BioNTech
2	2021-03-31	Pfizer-BioNTech

Call center

Reported	Outcome	VAERS-related outcome
2021-03-24	Unsuccessful
2021-09-30	Unsuccessful
2022-04-02	Unsuccessful

Free text

Release 6 — day 14, dose 1

2021-03-24

Symptoms: Body aches, blurred vision, headache

Release 6 — day 0, dose 2

2021-03-31

Systemic reaction (other): Dizziness

Release 6 — days 1–6 daily, dose 2

2021-04-03

Systemic reaction (other): Dizziness and blurred vision

2021-04-04

Systemic reaction (other): Dizziness and blurred vision

2021-04-05

Systemic reaction (other): Dizziness

Release 9 — 6 months, dose 2

2021-09-30

Symptoms: Worsening mensural cycles

Release 11 — 12 months, dose 2

2022-04-02

Symptoms: 2 miscarriages

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Abortion spontaneous	·	·	✓
SD	Headache	✓	✓	✓
SD	Menstrual disorder	·	·	✓
SD	Pain	✓	✓	✓
SD	Vision blurred	✓	✓	✓
SRO	Dizziness	✓	✓	✓
SRO	Vision blurred	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release